Home > PJ (current issue) > Christmas Miscellany 2003 | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7280 p854-855
20/27 December 2003

This article
Reprint
Photocopy

   

PDF 50K


Christmas miscellany summary


Why mistletoe is a Kiss-mas plant!

In this article, Joanne Barnes, Linda Anderson and David Phillipson, the authors of ‘Herbal medicines: a guide for healthcare professionals’ (2nd edition), discuss the links between mistletoe and Christmas, and explore some of the traditional and modern medicinal uses of “European” mistletoe


The word mistletoe relates to not one but hundreds of different species of perennial, evergreen, parasitic shrubs from different genera.1 “American” mistletoe is often referred to as Phoradendron leucarpum (Raf.) Rev. & M.C. Johnst., or P flavescens Nutt., although there are other species. “European” mistletoe is Viscum album L., and has three subspecies that are commonly recognised: platyspermum Kell., abietis Beck, and laxum Fiek.2 V album has yellowish-green, leathery, elliptical leaves and inconspicuous yellowish-green flowers. The fruit is a white, globular, sticky berry, which ripens in December. Red-berried mistletoe is V cruciatum, which grows on deciduous trees in southern Europe.

V album grows on many deciduous trees (extracting water and nutrients), including fruit trees such as apple and lime, throughout Europe, and two of the subspecies grow on conifers. In England, mistletoe (V album) is common, particularly in Herefordshire and in the south and south east. The National Mistletoe Survey, which began in 1994, has been unable to determine whether or not mistletoe is becoming rarer in the United Kingdom, although gardens, followed by orchards, are now the most common habitats.3 Mistletoe is scarce in northern England and is almost unknown in Scotland, except at Christmas when it may be found in homes and hostelries.

Kiss-mas time

V album was interwoven by ancient peoples into many myths and legends, several of which survive in some form today. V album and the oak trees upon which it grew were held in great reverence by the ancient Druids — mistletoe was believed to protect its possessor from evil, to be an antidote to poisons and to cure illnesses.4,5 It is claimed that the Druids used branches of mistletoe to announce the new year, and that this may explain today’s use of mistletoe as a Christmas decoration.4

The Christmas custom of kissing under a sprig of mistletoe hung above a door frame or from the middle of a ceiling is known to almost everyone, and many of us will have been willing (or not so willing) participants of this practice at some time. The precise origin of this custom is not clearly understood. The earliest documented case in England is said to date from the 16th century, although one suggestion is that the custom may relate to early beliefs that mistletoe had beneficial effects on fertility and conception.6 Another interpretation is that an exchange of kisses is a promise to marry and a prediction of happiness and long life.5 Allegedly, mistletoe kissing etiquette requires that a man should pluck a berry from the mistletoe branch under which he has kissed a woman and that once the last berry has been plucked, there can be no more kissing. Unwilling potential kissers will already have spotted how this could be used as a get-out clause, but a word of warning: hide the berries, do not eat them.

Traditional medicinal uses

Mistletoe (V album L.) is also reputed for its medicinal properties. For example, it has been used traditionally for lowering blood pressure — although it is not clear whether this relates to before or after kissing! Some of the earliest uses documented for mistletoe include treating diseases of the spleen, complaints associated with menstruation, infertility, ulcers and swellings or tumours, although it is not clear if V album was the species concerned.5 Several authors from the Middle Ages, and later, recommended mistletoe as a treatment for epilepsy and other nervous convulsive disorders. Part of the rationale for this was that in its growth cycle mistletoe does not touch the ground, so was deemed an appropriate remedy for “falling sickness”. Other uses that have been listed include bone fractures and labour pains.5

More recent traditional uses (for V album twigs) listed in standard pharmaceutical and herbal reference texts include hypertension, hypertensive headache, nervous tachycardia, chorea and hysteria.7 The German Commission E monograph states that mistletoe herb (consisting of fresh or dried younger branches with flowers and fruits) can be used for treating degenerative inflammation of the joints by stimulating cuti-visceral reflexes following local inflammation brought about by intradermal injections, and as palliative therapy for malignant tumours through non-specific stimulation.7

Mistletoe today

The use of mistletoe (V album) extracts in the treatment of cancer was first proposed by Rudolf Steiner, the founder of anthroposophical medicine, a spiritual and philosophical approach to health and illness, at the beginning of the 20th century.

Today, mistletoe extracts are widely used in Europe, particularly in Germany and Switzerland, in the treatment of different types of cancer, including breast, ovarian, urogenital, gastrointestinal, pancreatic and respiratory cancers. It is used both as an adjunct to conventional cancer chemotherapy and radiotherapy and, sometimes, as a single-agent approach.

There have been a number of randomised clinical trials of mistletoe preparations in the treatment of cancer, although systematic reviews of such trials have found that many of the studies have methodological limitations and have concluded that there is a lack of evidence to support the efficacy of mistletoe extracts as a cancer treatment. However, these reviews have included trials of several different preparations of mistletoe and the trials involved patients with different types of cancer. Against this background, a new systematic review is under way which will categorise included trials according to tumour type treated and will include sensitivity analyses according to the type of mistletoe preparation tested.8

Mistletoe extracts used in cancer treatment usually are administered by subcutaneous injection and, in some patients, this may cause a rise in temperature and skin reactions at the injection site. Preparations for oral administration are also available. Several licensed mistletoe preparations, which hold Product Licences of Right (PLRs), are available in the UK (eg, Iscador products) and mistletoe preparations can be prescribed by general practitioners on National Health Service prescriptions.

Mistle-aneous preparations

The constituents of mistletoe depend to some extent on the host tree on which the plant has grown. Moreover, as with other natural products, the precise phytochemical composition of mistletoe extracts will vary depending upon geographical, environmental, harvesting and processing factors. Many different preparations of mistletoe are available and, for the reasons given, the profile of constituents will differ qualitatively and quantitatively.

Several manufacturers’ products comprise aqueous extracts of mistletoe (some of which undergo fermentation), which are distinguished according to the host tree, such as apple, pine or spruce, on which the mistletoe has grown. Preparations from different host trees, administered according to different dosage regimens, are advocated for use in different types of cancer, although there is no sound evidence base for this. Important groups of constituents of mistletoe include the mistletoe lectins (high molecular weight polypeptides) and the viscotoxins (low molecular weight poly-peptides), both of which have pharma-cological and toxicological effects.9 For example, there is a vast scientific literature describing the immunomodulatory and cytotoxic activity of these constituents. Other constituents of mistletoe include alkaloids and flavonoids.9 Some mistletoe preparations are standardised on content of certain constituents, eg, mistletoe lectin-1 (ML-1).

Not berry good

Unlicensed products containing mistletoe are widely available via the internet. Some of these products contain only mistletoe as an active ingredient (monopreparations), whereas others combine mistletoe with other herbs, vitamins, minerals or, as in some traditional Chinese medicine patent products, animal parts.

Mistletoe berries are poisonous and, in the UK, products made with the berries must be licensed as medicinal products.10 Although, in practice, it is highly unlikely that any pharmacist today would be asked to sell mistletoe berries, at this time of year, visitors to pharmacies might want to watch out for a sprig or two of mistletoe hanging over the counter!

References

1. Anderson LA, Phillipson JD. Mistletoe — the magic herb. Pharm J 1982;229:437–9.
2. Foster S, Tyler VE. Tyler’s honest herbal, 4th edition. New York: The Haworth Herbal Press; 1999.
3. The National Mistletoe Survey. Available at: www.mistletoe.org.uk
4. Leyel CF (editor). A modern herbal. London: Jonathan Cape Ltd; 1979.
5. Büssing A. Introduction: history of mistletoe uses. In: Büssing A (ed) Mistletoe: the genus Viscum. The Netherlands: Harwood Academic Publishers; 2000. pp1–6.
6. Tainter FH. What does mistletoe have to do with Christmas? APSnet, December 2002, The American Phytopathological Society.
7. British Herbal Medicine Association. A guide to traditional herbal medicines. Bournemouth: British Herbal Medicine Association; 2003.
8. Horneber MA, Bueschel G, Huber R, Linde K, Richardson MA, Rostock M, Kaiser G. Mistletoe therapy in oncology (protocol for a Cochrane review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons Ltd; 2003.
9. Barnes J, Anderson LA, Phillipson JD. Herbal medicines. A guide for healthcare professionals. 2nd edition. London: Pharmaceutical Press; 2002.
10. The Medicines (Retail Sale or Supply of Herbal Remedies) Order 1977, Statutory Instrument No 2130. London: The Stationery Office; 1977.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal